Cargando…

A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)

Detalles Bibliográficos
Autores principales: Tan, Zhiyong, Wang, Haifeng, Wang, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389499/
https://www.ncbi.nlm.nih.gov/pubmed/36799855
http://dx.doi.org/10.1097/JS9.0000000000000097
_version_ 1785082314289577984
author Tan, Zhiyong
Wang, Haifeng
Wang, Jiansong
author_facet Tan, Zhiyong
Wang, Haifeng
Wang, Jiansong
author_sort Tan, Zhiyong
collection PubMed
description
format Online
Article
Text
id pubmed-10389499
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103894992023-08-01 A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777) Tan, Zhiyong Wang, Haifeng Wang, Jiansong Int J Surg Commentaries Lippincott Williams & Wilkins 2023-01-24 /pmc/articles/PMC10389499/ /pubmed/36799855 http://dx.doi.org/10.1097/JS9.0000000000000097 Text en Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
spellingShingle Commentaries
Tan, Zhiyong
Wang, Haifeng
Wang, Jiansong
A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title_full A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title_fullStr A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title_full_unstemmed A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title_short A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
title_sort commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (int j surg 2022; 104:106777)
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389499/
https://www.ncbi.nlm.nih.gov/pubmed/36799855
http://dx.doi.org/10.1097/JS9.0000000000000097
work_keys_str_mv AT tanzhiyong acommentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777
AT wanghaifeng acommentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777
AT wangjiansong acommentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777
AT tanzhiyong commentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777
AT wanghaifeng commentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777
AT wangjiansong commentaryonsystematicreviewandmetaanalysisofrandomizedcontrolledtrialsofperioperativeoutcomesandprognosisoftransurethralenblocresectionversusconventionaltransurethralresectionfornonmuscleinvasivebladdercancerintjsurg2022104106777